WWhat was it about this contrived stage that burst the banks of his storied theatricality? Drama is Richard E. Grant’s territory. Staying within the wingspan-range of Richard E. Grant is what Richard E. Grant does. And, yet,
amid a completely unchallenging environment of bozos he spontaneously exploded into an uncharacteristic display of ‘honesty’.

But what do we actually know about thespian Richard E. Grant, beyond him being a privately educated, hopelessly posh, aristocratic Englishman? Well, for a start, he’s not called Richard E. Grant, he did not attend Eton, he is not aristocratic and is not from England. But let’s not get bogged down in details!

What has this got do with the modern clinical trials landscape, I hear you ask? Well, when it comes to clinical trials it is important to get bogged down in details. Swathes of patient data, in volumes beyond our comprehension, are being generated, processed and regurgitated in a concentrated melting pot of super-charged enlightenment.

As AI emerges as a force within the currency and calculation clinical trials, its ability to establish the faithful data, while discarding (or in some cases including) amusing flights of fancy, such as blurting out that you’re ‘a traitor’,
will be crucial in a bid to control the datasphere.

And, in a game where the rules are always changing, control may be all we have left. Losing it doesn’t bear thinking about. Just ask Richard.

John Pinching
editor

PharmaTimes Media Ltd,
44 Maiden Lane
Covent Garden
London
WC2E 7LN
Tel: +44 (0)20 7240 6999
pharmatimes.com
Twitter: @PharmaTimes

MAGAZINE
John Pinching / editor
john.pinching@pharmatimes.com
Michelle Legrand / sales manager
michelle.legrand@pharmatimes.com

COMPETITIONS
Luci Sargood / business manager
luci.sargood@pharmatimes.com
Michelle Legrand / sales manager
michelle.legrand@pharmatimes.com
James Tansill / Marketing Executive
james.tansill@pharmatimes.com

PMGROUP
Tara Lovegrove / business director
 tara.lovegrove@pharmatimes.com
Iona Everson / group managing editor
iona.everson@pharmatimes.com
Karl Equi / executive director
karl.equi@pharmatimes.com


SUBSCRIPTIONS/REPRINTS
Digital and paper copies available free to qualifying readers: www.pharmatimes.com/subscribe
Tel: 01372 414 222
subscriptions@pharmatimes.com
Paper subscriptions available at £90.00 UK and £100.00 overseas per annum.

Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.

Material may not be reproduced in any form without the publisher’s written permission. © Copyright 2026 PharmaTimes Magazine. All rights reserved. PharmaTimes Magazine is published by PharmaTimes Media Ltd, which is registered as a limited company in England; No 09019637.